The Quiet Acquisition Wave Reshaping Outpatient Surgery
United Surgical Partners International – known in the industry simply as USPI – has been on a sustained buying spree across the American healthcare market, and the sellers are not the large hospital systems most people would expect. They are independent, physician-owned ambulatory surgery centers operating out of mid-sized markets: the kind of facilities that perform routine knee replacements, cataract surgeries, and colonoscopies five days a week without drawing much attention from the business press. These centers are profitable, well-run, and increasingly convinced that selling to a national operator is a smarter exit than staying independent.
USPI, a subsidiary of Tenet Healthcare, now operates well over 400 outpatient facilities across the country and continues to expand through targeted acquisitions rather than organic development alone. The company’s model is built on acquiring majority stakes in physician-owned centers while allowing the selling physicians to retain partial ownership – an arrangement that makes the deal appealing to doctors who want liquidity without fully walking away from their practices.
This is not a story about distressed sellers. These centers are selling from a position of strength.
Why Owners Are Choosing to Sell Now
The financial logic behind these deals is straightforward. An independent ambulatory surgery center in a regional market faces a set of structural pressures that compound over time: payer contract negotiations with major insurers, rising supply chain costs, growing administrative burden from regulatory compliance, and the capital requirements of keeping equipment current. A single-facility operator negotiating with a large commercial insurer is at a serious disadvantage compared to a national network that can push for better reimbursement rates across hundreds of locations. That rate differential, multiplied over thousands of cases annually, erodes the independent center’s margin in ways that do not show up dramatically in any single quarter but accumulate into a real problem over five to ten years.
Physicians who built these centers in the 1990s and early 2000s are also facing a generational transition. Many of the founding surgeons are now in their late 50s and 60s, approaching the end of their active practice years. Recruiting younger partners to buy in at full valuation is harder than it used to be – newly trained surgeons carry substantial debt and are often reluctant to take on equity risk in a facility they did not build. For founders, selling to USPI converts illiquid ownership into real capital while the center is still operating at peak performance, rather than watching valuation erode as the founding generation ages out.
There is also a strategic element that gets less attention: case volume migration. As hospital systems have expanded their own outpatient capabilities and competed aggressively for surgical volume, independent centers without referral network backing have found their case mix shifting. USPI’s scale gives acquired centers access to broader physician networks and, in some markets, preferred status with employers and insurers that independent operators cannot secure on their own.
What USPI Gets Out of the Deal
For USPI and its parent Tenet Healthcare, ambulatory surgery centers are a high-margin business that fits neatly into the broader shift of complex procedures away from expensive hospital settings. Procedures that once required inpatient stays – including total joints, spine cases, and certain cardiac interventions – are increasingly approved for outpatient settings by both commercial payers and Medicare. Every time that approval expands, the economic argument for owning outpatient infrastructure gets stronger. USPI is not acquiring these regional centers as a defensive move; it is acquiring them because the reimbursement environment is moving in a direction that makes outpatient surgical volume more valuable, not less.
The physician co-ownership model is also a retention tool. When a center sells to USPI, the physicians who remain as partial owners have a financial incentive to keep their surgical volume at that facility rather than migrating cases to a competing hospital or independent center. This alignment is deliberately structured into the deal terms, and it is part of why USPI’s acquisitions tend to retain case volume more reliably than acquisitions where physicians are bought out entirely and left with no stake in the outcome.
Regional markets that might look unattractive to a first glance – smaller cities, suburban corridors outside major metros – are actually where much of this activity is concentrated. These markets often have less competition for outpatient volume, more stable payer mixes, and physician communities that are highly influential in directing where patients receive care. A well-positioned center in a regional market with limited competition can generate returns that rival or exceed those of flashier urban acquisitions.
The Tension Physicians Are Not Talking About Publicly
Not every physician-owner who sells to USPI walks away satisfied. The retained equity stake – typically a minority position – means the selling physicians no longer control decisions about staffing, supply vendor contracts, scheduling protocols, or capital expenditures. Operational standardization is a core part of USPI’s integration strategy, and that standardization, while efficient at the network level, can feel like a loss of autonomy to physicians who spent decades building a center around their own clinical and operational preferences. This tension rarely surfaces in press releases, but it is a recurring point of friction in acquisitions across the broader sector – a pattern that mirrors what has played out in other service industries where regional operators have sold to large national acquirers and then navigated the gap between promised autonomy and day-to-day operational reality.
The centers that have not yet sold are watching closely. Some will hold out, betting that independent operation remains viable as long as they can maintain strong payer contracts and physician loyalty. Others are in early conversations with USPI or its competitors – including Optum, SCA Health, and AmSurg – running the math on whether the valuation multiple available today justifies selling before the window narrows. The question that does not have a clean answer yet is whether the centers that wait will be negotiating from the same position of strength five years from now, or whether holding out will simply mean selling later at a lower multiple to a buyer with fewer competing offers on the table.
